EUVIMEDEUVIMED entdecken
Crossref

Glycoprotein Nonmetastatic Melanoma Protein B (GPNMB) Immunohistochemistry Can Be a Useful Ancillary Tool to Identify Perivascular Epithelioid Cell Tumor

Sintawat Wangsiricharoen, Davis R Ingram, Rohini R Morey, Khalida Wani, Alexander J Lazar, Wei-Lien Wang

Modern Pathology · 2024

DOI: 10.1016/j.modpat.2024.100426 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Modern Pathology, 2024. Verfasst von Sintawat Wangsiricharoen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Pathology and Laboratory Medicine, Oregon H…. Hauptthemen laut MEDLINE: Melanoma, Perivascular Epithelioid Cell Neoplasms, Sarcoma, Receptors, Fc. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Perivascular epithelioid cell tumors (PEComas) are rare mesenchymal tumors that express smooth muscle and melanocytic makers. Diagnosis of PEComas can be challenging due to focal or lost expression of traditional immunohistochemical markers, limited availability of molecular testing, and morphological overlap with much more common smooth muscle tumors. This study evaluates the use of glycoprotein nonmetastatic melanoma protein B (GPNMB) immunohistochemical staining as a surrogate marker for TSC1/2/MTOR alteration or TFE3 rearrangement to differentiate PEComas from other mesenchymal tumors. Cathepsin K was also assessed for comparison. A total of 399 tumors, including PEComas, alveolar soft part sarcomas, and other histologic PEComa mimics, were analyzed using GPNMB and cathepsin K immunohistochemistry. GPNMB expression was seen in all PEComas and alveolar soft part sarcomas with the majority showing diffuse and moderate-to-strong labeling, whereas other sarcomas were negative or showed focal labeling. When a cutoff of diffuse and at least moderate staining was used, GPNMB demonstrated 95% sensitivity and 97% specificity in distinguishing PEComas from leiomyosarcoma, well-differentiated/dedifferentiated liposarcomas, and undifferentiated pleomorphic sarcomas. Cathepsin K with a cutoff of any labeling had lower sensitivity (78%) and similar specificity (94%) to GPNMB. This study highlights GPNMB as a highly sensitive marker for PEComas and suggests its potential use as an ancillary tool within a panel of markers for accurate classification of these tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaPerivascular Epithelioid Cell NeoplasmsSarcomaReceptors, FcHumansImmunohistochemistryCathepsin KBiomarkers, TumorGlycoproteinsBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsMembrane Glycoproteins

Stichwörter der Autor:innen

GPNMBMTORPEComaTFE3TSC1/2perivascular epithelioid cell tumor

Substanzen

Cathepsin KIgA receptorBiomarkers, TumorGlycoproteinsBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsGPNMB protein, humanMembrane GlycoproteinsReceptors, Fc

Autor:innen und Institutionen

  • Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Pathology and Laboratory Medicine, Oregon Health & Science University, Portland, Oregon.
  • Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department…
  • Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic…

Zitieren

APA

Wangsiricharoen, S., Ingram, D. R., Morey, R. R., Wani, K., Lazar, A. J., & Wang, W. L. (2024). Glycoprotein Nonmetastatic Melanoma Protein B (GPNMB) Immunohistochemistry Can Be a Useful Ancillary Tool to Identify Perivascular Epithelioid Cell Tumor. Modern Pathology. https://doi.org/10.1016/j.modpat.2024.100426

Vancouver

Wangsiricharoen S, Ingram DR, Morey RR, Wani K, Lazar AJ, Wang WL. Glycoprotein Nonmetastatic Melanoma Protein B (GPNMB) Immunohistochemistry Can Be a Useful Ancillary Tool to Identify Perivascular Epithelioid Cell Tumor. Modern Pathology. 2024. doi:10.1016/j.modpat.2024.100426

BibTeX
@article{Wangsiricharoen2024,
  author = {Wangsiricharoen, Sintawat and Ingram, Davis R and Morey, Rohini R and Wani, Khalida and Lazar, Alexander J and Wang, Wei-Lien},
  title = {Glycoprotein Nonmetastatic Melanoma Protein B (GPNMB) Immunohistochemistry Can Be a Useful Ancillary Tool to Identify Perivascular Epithelioid Cell Tumor},
  journal = {Modern Pathology},
  year = {2024},
  doi = {10.1016/j.modpat.2024.100426}
}
Kostenlos starten →